跳至主要内容
临床试验/IRCT20171109037332N2
IRCT20171109037332N2尚未招募3 期

Clinical Trial on the efficacy of low dose naltrexone vs placebo on pain intensity in Trigeminal Neuralgia and Chronic migraine patients

Kerman University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • According to ICHD3 criteria, they are diagnosed with TN or chronic headache.
  • Be over 18 years old
  • Have the necessary cooperation to participate in the study.

排除标准

  • Patient non-cooperation
  • The patient is pregnant or breastfeeding.
  • If the patient uses opioid analgesics or inhales opioids
  • If the patient regularly uses anti-inflammatory drugs.
  • Known allergy or reaction to naltrexone
  • If the patient consumes alcohol and can not refrain from consuming it during the study.
  • The patient has rheumatic or autoimmune diseases
  • The patient has been diagnosed with a mental illness that disrupts his or her collaboration in the study.

研究者

相似试验